Over time, migraine treatment options have evolved, but unfortunately, speed of migraine relief has been compromised in favor of convenience.
Doctors prefer pills over injectable pens when it comes to treating migraines, which is an unfortunate truth for patients seeking fast relief for their attacks, or who are suffering from migraines with nausea that prevent them from taking their pills.
The challenge was to change that mindset with the introduction of ZEMBRACE SymTouch—a simplified, 3 mg sumatriptan pen that features one of the thinnest needles in the market and delivers fast, powerful migraine relief.
The solution? A simple campaign. Literally.
Through the use of simple exclamations enthusiastically punctuated by the ZEMBRACE SymTouch device, a pen-centric campaign was created to stir up excitement around this exciting treatment for both physicians and patients alike.
For physicians, it was about highlighting how “Simple!” this easy-to-use device was, and how it was also a simple solution for the difficult complaints that migraine patients have had for years regarding oral treatments.
For patients, it was about highlighting that “A-ha!” moment, when they finally find a migraine treatment that provides them with the relief that they’ve been searching for.
For Promius Pharma, it was a successful entrance into the neurology category. To date, the campaign continues to drive sales while encouraging physicians to see migraines differently. It’s as simple as that.